Purchase Order 75N92025P00290

Award Date 8/1/25
Potential Completion Date 7/31/26
Potential Value $85K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
This federal contract award to Pacific Biosciences of California, Inc. is for the procurement of PacBio Revio Sequencer Systems by the National Human Genome Research Institute (NHGRI), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $540,088.00 and is a firm fixed-price purchase order with an ultimate completion date of August 12, 2024. The award was made on June 26, 2024, and there was no set-aside designation used. Pacific Biosciences is a...
This federal contract award is for the delivery of REVIO system parts, labor, and consumables required for repair and planned maintenance of PacBio's proprietary DNA sequencing systems. The $85,000 firm-fixed price contract was awarded to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing equipment, by a civilian federal agency, the Plains Area division. The contract does not have a set-aside designation and will run through October 17,...
This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Pacific Biosciences of California, Inc. for the delivery of REVIO SPRQ REAGENT KIT. The contract has a ceiling value of $137,088.00 and a period of performance through February 28, 2025. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to...
This is a $10,775.28 firm-fixed price delivery order contract awarded by the Plains Area agency of the U.S. federal government to Pacific Biosciences of California, Inc. for the provision of PacBio Revio reagents and consumables to support whole genome sequencing projects. The contract has an ultimate completion date of September 6, 2024. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are widely utilized by various...
This is a firm-fixed-price delivery order contract awarded to Pacific Biosciences of California, Inc. by the Plains Area division of a civilian federal agency. The contract, valued at $75,000.00, is for the provision of REVIO service and support for DNA sequencing systems, specifically the Sequel and Sequel II platforms, over the period of performance from August 2024 through September 2025. Pacific Biosciences is the original equipment manufacturer for these proprietary long-read DNA sequencing...
The U.S. Department of Agriculture awarded a $40,034.33 firm-fixed price delivery order to Pacific Biosciences of California, Inc. for the supply of PacBio Revio DNA sequencing consumables. This award is part of a $13.5 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract the company holds with the USDA Agricultural Research Service to provide specialized scientific equipment, reagents, and services related to their Sequel and Sequel II sequencing platforms. Pacific...
This is a firm-fixed price delivery order contract awarded by the Central Program Planning Coordination and Support (VPARSCPPCS-A) program of the U.S. government to Pacific Biosciences of California, Inc., a for-profit biotechnology company. The contract is for the procurement of a REVIO SMRT CELLS SYSTEM, a specialized DNA and RNA sequencing system manufactured by Pacific Biosciences. The contract has a ceiling value of $92,199.84 and a period of performance through December 31, 2025. This...
This is a firm fixed-price definitive contract awarded by the Department of Health and Human Services' Food and Drug Administration to Pacific Biosciences of California, Inc., a small business manufacturer of specialized scientific equipment and consumables. The contract, valued at $736,000.00, is for the provision of Pacific Biosciences' Sequel and Sequel II real-time DNA/RNA sequencing systems, along with associated reagent kits, adapters, and software to support the FDA's genomic research...
This is a firm-fixed price delivery order contract awarded to Pacific Biosciences of California, Inc., a manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $20,510.00 award is for the purchase of REVIO System DNA supplies under the GBRU PAC BIO PURCHASE requirement, with an ultimate completion date of August 24, 2024. The contract is issued by the Southeast Area civilian agency of the federal government, and does not utilize any set-aside...

This is a $85,000.00 firm-fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI) to Pacific Biosciences of California, Inc. for a service contract to provide the Pacific Biosciences Revio, a new sequencing system. The contract has an ultimate completion date of July 31, 2026. Pacific Biosciences is a for-profit biotechnology company that specializes in advanced DNA and RNA sequencing technologies. This contract is not a set-aside.

Pacific Biosciences holds two significant Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicles with the U.S. Department of Agriculture (USDA) Agricultural Research Service ($13.5 million) and the Food and Drug Administration (FDA) ($1 million), demonstrating the company's strategic importance in supporting federal genomic research efforts across civilian agencies.

Generated 8/2/25, 9:52 AM